Viscofan stock holds its ground as 2025 earnings stay firm

Viscofan stock reflects 2025 earnings resilience as revenue reached EUR 1.25 billion and net profit came in at EUR 141.8 million.

Viscofan (ES0184262212) showed 2025 resilience with revenue of EUR 1.25 billion and net profit of EUR 141.8 million, while its adjusted EBITDA reached EUR 273.5 million in the same period. The company is listed in Spain, and the latest published figures provide the main reference point for Viscofan stock on 19 July 2026.

Revenue and profit stay firm

Viscofan reported 2025 revenue of EUR 1.25 billion, up from EUR 1.21 billion a year earlier, which gives investors a clear year-over-year comparison. Net profit for 2025 was EUR 141.8 million, while adjusted EBITDA was EUR 273.5 million, underscoring the group’s ability to convert sales into operating cash generation.

The comparison matters because the 2025 revenue increase came against a larger base than in 2024, yet the company still held sales above EUR 1.2 billion. That combination is more relevant than a simple growth label, especially for a cash-generative industrial business with steady demand.

Margin level remains the focus

Viscofan's 2025 adjusted EBITDA of EUR 273.5 million implies a margin of about 21.9% on EUR 1.25 billion of revenue. That margin level is the central number for the group because it shows how much of each sales euro remained after operating costs.

For a packaging company, a margin above 20% is a useful benchmark, and Viscofan stayed above that line in 2025. The market usually reads that as a sign of pricing discipline and production efficiency, even before any new catalyst appears.

2025 figures set the base

Viscofan's 2025 figures also included a net profit margin of about 11.3%, based on EUR 141.8 million of profit on EUR 1.25 billion of revenue. The earnings base therefore remains solid enough to anchor valuation discussions without needing to lean on speculation.

That leaves the 2026 focus on whether the company can protect margins while volume trends and input costs move through the year. The latest annual numbers give investors a concrete reference for any future update.

Packaging demand matters

Viscofan is best known for cellulosic, collagen, fibrous, and plastic casings used in food packaging, so the product story is tied directly to operating consistency rather than consumer branding. In 2025, the business model continued to rely on broad global demand across sausage and processed meat applications.

That makes the casings portfolio the key representative product line for understanding the company. If volume or pricing shifts, they usually show up first in revenue and EBITDA rather than in flashy product launches.

Market value and listing

Viscofan stock is traded in euros on the Spanish market, and the most recent annual figures frame the current equity story. When the next market quote becomes relevant, it will matter less as a headline number than as a test of whether the 2025 earnings base still supports the valuation.

The 2025 report already supplies the key data point: EUR 1.25 billion in revenue, EUR 273.5 million in adjusted EBITDA, and EUR 141.8 million in net profit. Those three figures define the starting point for the stock now.

Casings remain the core

Cellulosic, collagen, fibrous, and plastic casings are the core products that shape Viscofan's revenue mix. Their importance is visible in the 2025 numbers, where revenue stayed above EUR 1.2 billion and EBITDA remained comfortably positive at EUR 273.5 million.

For investors, that product mix matters because it ties the company to a recurring industrial demand base rather than to one-off orders. The 2025 earnings profile shows a business that is still operating with scale and efficiency.

Stock view in euros

Viscofan stock is quoted in euros on the Spanish market and trades against a 2025 earnings base that produced EUR 141.8 million in net profit. The companys latest annual results therefore remain the main reference for valuation until the next report is published.

With revenue at EUR 1.25 billion and adjusted EBITDA at EUR 273.5 million in 2025, the stock has a clear fundamental starting point. That is the number set that now matters most.